Shareholders Equity: The sum of preferred and common equity items.
InMed Pharmaceuticals Inc. (INM) had Shareholders Equity of $6.89M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-2.97M |
|
-- |
|
-- |
|
$2.82M |
|
$-2.82M |
|
$0.02M |
|
$-2.79M |
|
$-2.79M |
|
$-2.79M |
|
$-2.79M |
|
$-2.97M |
|
$-2.79M |
|
$-2.82M |
|
$-2.77M |
|
4.05M |
|
4.05M |
|
$-0.73 |
|
$-0.73 |
|
| Balance Sheet Financials | |
$6.89M |
|
$0.64M |
|
$2.25M |
|
$9.13M |
|
$2.21M |
|
$0.03M |
|
$0.03M |
|
$2.24M |
|
$6.89M |
|
$5.39M |
|
|
Shareholders Equity |
$6.89M |
3.31M |
|
| Cash Flow Statement Financials | |
$-5.68M |
|
$0.00M |
|
$0.09M |
|
$10.74M |
|
$5.16M |
|
$-5.58M |
|
$0.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.12 |
|
-- |
|
-- |
|
0.00 |
|
0.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.68M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-40.51% |
|
-51.76% |
|
-30.57% |
|
-40.33% |
|
$2.08 |
|
$-1.40 |
|
$-1.40 |
|